BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mortensen MB, Falk E. Primary Prevention With Statins in the Elderly. Journal of the American College of Cardiology 2018;71:85-94. [DOI: 10.1016/j.jacc.2017.10.080] [Cited by in Crossref: 87] [Cited by in F6Publishing: 89] [Article Influence: 17.4] [Reference Citation Analysis]
Number Citing Articles
1 Murphy E, Cooney MT, Mcevoy JW. Atherosclerotic Cardiovascular Disease Prevention in the Older Adult: Part 2. Contemporary Cardiology 2023. [DOI: 10.1007/978-3-031-16594-8_2] [Reference Citation Analysis]
2 Nanna MG, Abdullah A, Mortensen MB, Navar AM. Primary prevention statin therapy in older adults. Curr Opin Cardiol 2023;38:11-20. [PMID: 36598445 DOI: 10.1097/HCO.0000000000001003] [Reference Citation Analysis]
3 Nanna MG, Nelson AJ, Haynes K, Shambhu S, Eapen Z, Cziraky MJ, Calvert SB, Pagidipati NJ, Granger CB. Lipid‐lowering treatment among older patients with atherosclerotic cardiovascular disease. J American Geriatrics Society 2022. [DOI: 10.1111/jgs.18172] [Reference Citation Analysis]
4 Zhang K, Ju Y, Yang D, Cao M, Liang H, Leng J. Association between arteriosclerosis and the risk of falls in the elderly.. [DOI: 10.21203/rs.3.rs-2245022/v1] [Reference Citation Analysis]
5 Rikhi R, Shapiro MD. Assessment of Atherosclerotic Cardiovascular Disease Risk in Primary Prevention. J Cardiopulm Rehabil Prev 2022;42:397-403. [PMID: 36342682 DOI: 10.1097/HCR.0000000000000746] [Reference Citation Analysis]
6 Negi P, Heikkilä T, Vuorenpää K, Tuunainen E, Nammas W, Maaniitty T, Knuuti J, Metso J, Lövgren J, Jauhiainen M, Lamminmäki U, Pettersson K, Saraste A. Time-resolved fluorescence based direct two-site apoA-I immunoassays and their clinical application in patients with suspected obstructive coronary artery disease. Front Cardiovasc Med 2022;9:912578. [PMID: 36312264 DOI: 10.3389/fcvm.2022.912578] [Reference Citation Analysis]
7 Rittger H, Leistner DM, Hardt R, Dörr M, Hambrecht R, Reibis R, Schellong S, Schirmer SH, Wolf A, Simm A, Müller-werdan U, Landmesser U. Cholesterinsenkende Therapie bei älteren Patienten. Kardiologie 2022. [DOI: 10.1007/s12181-022-00575-z] [Reference Citation Analysis]
8 Herrington G, Riche DM. Part I: Interactive case: Hyperlipidemia management for special populations. J Am Coll Clin Pharm 2022;5:1011-1015. [DOI: 10.1002/jac5.1688] [Reference Citation Analysis]
9 Malik AO, Chen H, Tang F, Chan PS, Cooper A, Gomes MB, Hejjaji V, Ji L, Khunti K, Kosiborod M, Nicolucci A, Peri-Okonny PA, Shestakova MV, Vora J, Watada H, Arnold SV. Association of country economy and socioeconomic factors on risk factor control for primary prevention of cardiovascular disease in patients with diabetes mellitus: Insights from the DISCOVER Study. Indian Heart J 2022:S0019-4832(22)00112-2. [PMID: 35926587 DOI: 10.1016/j.ihj.2022.07.008] [Reference Citation Analysis]
10 Lei Z, Li B, Li B, Peng W. Predictors and prognostic impact of left ventricular ejection fraction trajectories in patients with ST-segment elevation myocardial infarction. Aging Clin Exp Res 2022;34:1429-38. [PMID: 35147922 DOI: 10.1007/s40520-022-02087-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Zhao M, Ren L, Zhou Z, Wang T, Li J. The Association Between Statin Use and Risk of Chronic Kidney Disease in Community-Dwelling Older People in Shanghai, China. CLEP 2022;Volume 14:779-88. [DOI: 10.2147/clep.s360395] [Reference Citation Analysis]
12 Lucchi T. Lipid management. Pathy's Principles and Practice of Geriatric Medicine 2022. [DOI: 10.1002/9781119484288.ch31] [Reference Citation Analysis]
13 Stens O, Neutel B, Goodman EL. An Ounce of Prevention, a Pound of Complications: A Case of Statin-Induced Necrotizing Myopathy in a Frail Elderly Patient. Geriatrics 2022;7:33. [DOI: 10.3390/geriatrics7020033] [Reference Citation Analysis]
14 Bie L, Niu J, Wu S, Zheng R, Xu M, Lu J, Wang T, Zhao Z, Wang S, Lin H, Dai M, Zhang D, Chen Y, Bi Y, Wang W, Ning G, Li M, Xu Y. Negative Risk Markers for Cardiovascular Risk Evaluation in Chinese Adults. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.800671] [Reference Citation Analysis]
15 Kim S, Choi H, Won CW. Moderate-intensity statin use for primary prevention for more than 5 years is associated with decreased all-cause mortality in 75 years and older. Archives of Gerontology and Geriatrics 2022. [DOI: 10.1016/j.archger.2022.104644] [Reference Citation Analysis]
16 Lech S, O'Sullivan JL, Romanescu L, Nordheim J, Gellert P, Kuhlmey A, Yasar S. Statin use in dementia-Review and comparison of guideline recommendations. Int J Geriatr Psychiatry 2022;37. [PMID: 34787935 DOI: 10.1002/gps.5653] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Su X, Zheng D, Wang M, Zuo Y, Wen J, Zhai Q, Zhang Y, He Y. Low density lipoprotein cholesterol is associated with increased risk of cardiovascular disease in participants over 70 years old: A prospective cohort study. Nutr Metab Cardiovasc Dis 2021:S0939-4753(21)00507-X. [PMID: 34893412 DOI: 10.1016/j.numecd.2021.10.009] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Zhu Y, Chiang CW, Wang L, Brock G, Milks MW, Cao W, Zhang P, Zeng D, Donneyong M, Li L. A multistate transition model for statin-induced myopathy and statin discontinuation. CPT Pharmacometrics Syst Pharmacol 2021;10:1236-44. [PMID: 34562311 DOI: 10.1002/psp4.12691] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Hsu J, Iversen T, Price M, Moger TA, Tevis D, Hagen TP, Dow WH. Myocardial Infarction Care Among The Elderly: Declining Treatment With Increasing Age In Two Countries. Health Aff (Millwood) 2021;40:1483-90. [PMID: 34495733 DOI: 10.1377/hlthaff.2021.00108] [Reference Citation Analysis]
20 Whelton SP, McAuley PA, Dardari Z, Orimoloye OA, Michos ED, Brawner CA, Ehrman JK, Keteyian SJ, Blaha MJ, Al-Mallah MH. Fitness and Mortality Among Persons 70 Years and Older Across the Spectrum of Cardiovascular Disease Risk Factor Burden: The FIT Project. Mayo Clin Proc 2021;96:2376-85. [PMID: 34366139 DOI: 10.1016/j.mayocp.2020.12.039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Miller BF, Thyfault JP. Exercise-Pharmacology Interactions: Metformin, Statins, and Healthspan. Physiology (Bethesda) 2020;35:338-47. [PMID: 32783612 DOI: 10.1152/physiol.00013.2020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
22 Awad K, Mohammed M, Zaki MM, Abushouk AI, Lip GYH, Blaha MJ, Lavie CJ, Toth PP, Jukema JW, Sattar N, Banach M; Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group and the International Lipid Expert Panel (ILEP). Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies. BMC Med 2021;19:139. [PMID: 34154589 DOI: 10.1186/s12916-021-02009-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
23 Yashima F, Hara M, Inohara T, Jinzaki M, Shimizu H, Fukuda K, Tanaka M, Yamamoto M, Watanabe Y, Naganuma T, Shirai S, Yamawaki M, Tada N, Yamanaka F, Mizutani K, Ueno H, Tabata M, Takagi K, Hayashida K; OCEAN-TAVI registry. Statin therapy for patients with aortic stenosis who underwent transcatheter aortic valve implantation: a report from a Japanese multicentre registry. BMJ Open 2021;11:e044319. [PMID: 34117043 DOI: 10.1136/bmjopen-2020-044319] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Cho Y, Jeong Y, Seo DH, Ahn SH, Hong S, Suh YJ, Kim SH. Use of statin for the primary prevention of cardiovascular outcomes in elderly patients: A propensity-matched cohort study. Atherosclerosis 2021;328:92-9. [PMID: 34126505 DOI: 10.1016/j.atherosclerosis.2021.05.022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
25 Mortensen MB, Nordestgaard BG. 2019 vs. 2016 ESC/EAS statin guidelines for primary prevention of atherosclerotic cardiovascular disease. Eur Heart J 2020;41:3005-15. [PMID: 32227172 DOI: 10.1093/eurheartj/ehaa150] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 11.0] [Reference Citation Analysis]
26 Wardlaw JM, Debette S, Jokinen H, De Leeuw FE, Pantoni L, Chabriat H, Staals J, Doubal F, Rudilosso S, Eppinger S, Schilling S, Ornello R, Enzinger C, Cordonnier C, Taylor-Rowan M, Lindgren AG. ESO Guideline on covert cerebral small vessel disease. Eur Stroke J 2021;6:CXI-CLXII. [PMID: 34414301 DOI: 10.1177/23969873211012132] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
27 Jhaveri A, Sibley RA, Spatz ES, Dodson J. Aspirin, Statins, and Primary Prevention: Opportunities for Shared Decision Making in the Face of Uncertainty. Curr Cardiol Rep 2021;23:67. [PMID: 33961154 DOI: 10.1007/s11886-021-01499-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
28 Pereira B, Mazzitelli M, Milinkovic A, Moyle G, Ranasinghe S, Mandalia S, Pozniak A, Asboe D, Nelson M, Al-Hussaini A, Boffito M. Use of Coronary Artery Calcium Scoring to Improve Cardiovascular Risk Stratification and Guide Decisions to Start Statin Therapy in People Living With HIV. J Acquir Immune Defic Syndr 2020;85:98-105. [PMID: 32398558 DOI: 10.1097/QAI.0000000000002400] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
29 Maung HH. What's my age again? Age categories as interactive kinds. Hist Philos Life Sci 2021;43:36. [PMID: 33694016 DOI: 10.1007/s40656-021-00388-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
30 Spence JD. It's time to stop the nonsense of withholding lipid lowering therapy on account of age. Atherosclerosis 2021;323:56. [PMID: 33583573 DOI: 10.1016/j.atherosclerosis.2021.01.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Zhou Z, Ofori-Asenso R, Curtis AJ, Breslin M, Wolfe R, McNeil JJ, Murray AM, Ernst ME, Reid CM, Lockery JE, Woods RL, Tonkin AM, Nelson MR. Association of Statin Use With Disability-Free Survival and Cardiovascular Disease Among Healthy Older Adults. J Am Coll Cardiol 2020;76:17-27. [PMID: 32616158 DOI: 10.1016/j.jacc.2020.05.016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
32 Hein L, Seifert R. Neue Arzneimittel 2020. Arzneiverordnungs-Report 2021 2021. [DOI: 10.1007/978-3-662-63825-5_2] [Reference Citation Analysis]
33 White AMB, Mishcon HR, Redwanski JL, Hills RD. Statin Treatment in Specific Patient Groups: Role for Improved Cardiovascular Risk Markers. JCM 2020;9:3748. [DOI: 10.3390/jcm9113748] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
34 Lavie G, Hoshen M, Leibowitz M, Benis A, Akriv A, Balicer R, Reges O. Statin Therapy for Primary Prevention in the Elderly and Its Association with New-Onset Diabetes, Cardiovascular Events, and All-Cause Mortality. Am J Med 2021;134:643-52. [PMID: 33217370 DOI: 10.1016/j.amjmed.2020.09.058] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
35 Spence JD. Management of asymptomatic carotid stenosis. Ann Transl Med 2020;8:1262. [PMID: 33178794 DOI: 10.21037/atm-20-975] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
36 Gencer B, Marston NA, Im K, Cannon CP, Sever P, Keech A, Braunwald E, Giugliano RP, Sabatine MS. Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials. Lancet 2020;396:1637-43. [PMID: 33186535 DOI: 10.1016/S0140-6736(20)32332-1] [Cited by in Crossref: 90] [Cited by in F6Publishing: 69] [Article Influence: 30.0] [Reference Citation Analysis]
37 Mortensen MB, Nordestgaard BG. Elevated LDL cholesterol and increased risk of myocardial infarction and atherosclerotic cardiovascular disease in individuals aged 70-100 years: a contemporary primary prevention cohort. Lancet 2020;396:1644-52. [PMID: 33186534 DOI: 10.1016/S0140-6736(20)32233-9] [Cited by in Crossref: 69] [Cited by in F6Publishing: 55] [Article Influence: 23.0] [Reference Citation Analysis]
38 Spence JD, Azarpazhooh MR, Larsson SC, Bogiatzi C, Hankey GJ. Stroke Prevention in Older Adults: Recent Advances. Stroke 2020;51:3770-7. [PMID: 33121384 DOI: 10.1161/STROKEAHA.120.031707] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
39 Chitralli D, Raheja R, Br K. Clinical Rhabdomyolysis With Acute Kidney Injury Secondary to High-Intensity Rosuvastatin Use: A Case Report. Cureus 2020. [DOI: 10.7759/cureus.10932] [Reference Citation Analysis]
40 Agustini B, Mohebbi M, Woods RL, McNeil JJ, Nelson MR, Shah RC, Murray AM, Ernst ME, Reid CM, Tonkin A, Lockery JE, Berk M; ASPREE Investigator Group. Association Between Statin Use and Depressive Symptoms in a Large Community-Dwelling Older Population Living in Australia and the USA: A Cross-Sectional Study. CNS Drugs 2019;33:685-94. [PMID: 31062260 DOI: 10.1007/s40263-019-00633-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
41 Spence JD. Recent advances in preventing recurrent stroke. F1000Res 2020;9:F1000 Faculty Rev-1012. [PMID: 32864099 DOI: 10.12688/f1000research.23199.1] [Reference Citation Analysis]
42 Guo Y, Li Y, Liu X, Cui Y, Zhao Y, Sun S, Jia Q, Chai Q, Gong G, Zhang H, Liu Z. Assessing the effectiveness of statin therapy for alleviating cerebral small vessel disease progression in people ≥75 years of age. BMC Geriatr 2020;20:292. [PMID: 32807086 DOI: 10.1186/s12877-020-01682-w] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
43 Mortensen MB, Nordestgaard BG. Statin Use in Primary Prevention of Atherosclerotic Cardiovascular Disease According to 5 Major Guidelines for Sensitivity, Specificity, and Number Needed to Treat. JAMA Cardiol 2019;4:1131-8. [PMID: 31577339 DOI: 10.1001/jamacardio.2019.3665] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 9.3] [Reference Citation Analysis]
44 Raygor V, Khera A. New Recommendations and Revised Concepts in Recent Guidelines on the Management of Dyslipidemias to Prevent Cardiovascular Disease: the 2018 ACC/AHA and 2019 ESC/EAS Guidelines. Curr Cardiol Rep 2020;22:87. [PMID: 32647997 DOI: 10.1007/s11886-020-01331-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
45 Rocha Martinez TLD. Treatment of dyslipidemia in the elderly patients. IJFCM 2020;4:89-90. [DOI: 10.15406/ijfcm.2020.04.00192] [Reference Citation Analysis]
46 Kim S, Choi H, Won CW. Effects of Statin Use for Primary Prevention among Adults Aged 75 Years and Older in the National Health Insurance Service Senior Cohort (2002-2015). Ann Geriatr Med Res 2020;24:91-8. [PMID: 32743329 DOI: 10.4235/agmr.20.0028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
47 Furlan G, Caduff-Janosa P, Sottosanti L, Cappello E, Valdiserra G, Tuccori M. Drug Safety in Geriatric Patients: Current Status and Proposed Way Forward. Drug Saf 2020;43:853-66. [PMID: 32500271 DOI: 10.1007/s40264-020-00949-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
48 Mortensen MB, Fuster V, Muntendam P, Mehran R, Baber U, Sartori S, Falk E. Negative Risk Markers for Cardiovascular Events in the Elderly. J Am Coll Cardiol 2019;74:1-11. [PMID: 31272534 DOI: 10.1016/j.jacc.2019.04.049] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 16.7] [Reference Citation Analysis]
49 Rosada A, Kassner U, Weidemann F, König M, Buchmann N, Steinhagen-Thiessen E, Spira D. Hyperlipidemias in elderly patients: results from the Berlin Aging Study II (BASEII), a cross-sectional study. Lipids Health Dis 2020;19:92. [PMID: 32410691 DOI: 10.1186/s12944-020-01277-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
50 Tan M, MacEachern MP. Treating Dyslipidemias in the Primary Prevention of Atherosclerotic Cardiovascular Disease in Older Adults with Diabetes Mellitus. Clin Geriatr Med 2020;36:457-76. [PMID: 32586475 DOI: 10.1016/j.cger.2020.04.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
51 Zaric B, Obradovic M, Trpkovic A, Banach M, Mikhailidis DP, Isenovic ER. Endothelial Dysfunction in Dyslipidaemia: Molecular Mechanisms and Clinical Implications. CMC 2020;27:1021-40. [DOI: 10.2174/0929867326666190903112146] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
52 Ratcliffe F, Rothwell PM. The case for statin use to reduce perioperative adverse cardiovascular and cerebrovascular events. Br J Anaesth 2020;124:525-34. [PMID: 32111371 DOI: 10.1016/j.bja.2020.01.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
53 Bogiatzi C, Azarpazhooh MR, Spence JD. Choosing the right therapy for a patient with asymptomatic carotid stenosis. Expert Rev Cardiovasc Ther 2020;18:53-63. [PMID: 32043917 DOI: 10.1080/14779072.2020.1729127] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
54 O'Neill D, Stone NJ, Forman DE. Primary Prevention Statins in Older Adults: Personalized Care for a Heterogeneous Population. J Am Geriatr Soc 2020;68:467-73. [PMID: 31967323 DOI: 10.1111/jgs.16330] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
55 Zhou Z, Albarqouni L, Curtis AJ, Breslin M, Nelson M. The Safety and Tolerability of Statin Therapy in Primary Prevention in Older Adults: A Systematic Review and Meta-analysis. Drugs Aging 2020;37:175-85. [DOI: 10.1007/s40266-019-00736-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
56 Richard M F, Matthew R F, Tapan K C. Are statins overprescribed? J Cardiovasc Med Cardiol 2020;7:001-001. [DOI: 10.17352/2455-2976.000102] [Reference Citation Analysis]
57 Toth EL, Clarke JD, Csanaky IL, Cherrington NJ. Interaction of Oatp1b2 expression and nonalcoholic steatohepatitis on pravastatin plasma clearance. Biochem Pharmacol 2020;174:113780. [PMID: 31881192 DOI: 10.1016/j.bcp.2019.113780] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
58 Choi KH, Seo WK, Park MS, Kim JT, Chung JW, Bang OY, Kim GM, Song TJ, Kim BJ, Heo SH, Jung JM, Oh KM, Kim CK, Yu S, Park KY, Kim JM, Park JH, Choi JC, Hwang YH, Kim YJ. Effect of Statin Therapy on Outcomes of Patients With Acute Ischemic Stroke and Atrial Fibrillation. J Am Heart Assoc 2019;8:e013941. [PMID: 31826725 DOI: 10.1161/JAHA.119.013941] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
59 Piepoli MF, Abreu A, Albus C, Ambrosetti M, Brotons C, Catapano AL, Corra U, Cosyns B, Deaton C, Graham I, Hoes A, Lochen ML, Matrone B, Redon J, Sattar N, Smulders Y, Tiberi M. Update on cardiovascular prevention in clinical practice: A position paper of the European Association of Preventive Cardiology of the European Society of Cardiology. Eur J Prev Cardiol 2020;27:181-205. [PMID: 31826679 DOI: 10.1177/2047487319893035] [Cited by in Crossref: 119] [Cited by in F6Publishing: 120] [Article Influence: 29.8] [Reference Citation Analysis]
60 Spence JD. The need for clinical judgement in the application of evidence-based medicine. BMJ EBM 2020;25:172-7. [DOI: 10.1136/bmjebm-2019-111300] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
61 Hawley CE, Roefaro J, Forman DE, Orkaby AR. Statins for Primary Prevention in Those Aged 70 Years and Older: A Critical Review of Recent Cholesterol Guidelines. Drugs Aging 2019;36:687-99. [PMID: 31049807 DOI: 10.1007/s40266-019-00673-w] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
62 Aksenova AV, Oshchepkova EV, Orlovsky AA, Chazova IE. Arterial hypertension in elderly and senile patients: clinical characteristics and treatment quality (according to the national register of arterial hypertension). SMJ 2019;34:73-86. [DOI: 10.29001/2073-8552-2019-34-3-73-86] [Reference Citation Analysis]
63 Mortensen MB, Fuster V, Mehran R, Baber U, Falk E. Reply. Journal of the American College of Cardiology 2019;74:2331-2332. [DOI: 10.1016/j.jacc.2019.09.001] [Reference Citation Analysis]
64 Horodinschi RN, Stanescu AMA, Bratu OG, Pantea Stoian A, Radavoi DG, Diaconu CC. Treatment with Statins in Elderly Patients. Medicina (Kaunas) 2019;55:E721. [PMID: 31671689 DOI: 10.3390/medicina55110721] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
65 Juraschek SP, Daya N, Appel LJ, Miller ER 3rd, Matsushita K, Michos ED, Windham BG, Ballantyne CM, Selvin E. Subclinical Cardiovascular Disease and Fall Risk in Older Adults: Results From the Atherosclerosis Risk in Communities Study. J Am Geriatr Soc 2019;67:1795-802. [PMID: 31493355 DOI: 10.1111/jgs.16041] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
66 Kiel S, Zimak C, Schmidt CO, Chenot J. Effekt der ambulanten geriatrischen Komplexbehandlung auf Polypharmazie und potenziell inadäquate Arzneimittel – eine Beobachtungsstudie. Z Gerontol Geriat 2020;53:416-22. [DOI: 10.1007/s00391-019-01589-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
67 Pallazola VA, Sathiyakumar V, Ogunmoroti O, Fashanu O, Jones SR, Santos RD, Toth PP, Bittencourt MS, Duncan BB, Lotufo PA, Bensenor IM, Blaha MJ, Martin SS. Impact of improved low-density lipoprotein cholesterol assessment on guideline classification in the modern treatment era-Results from a racially diverse Brazilian cross-sectional study. J Clin Lipidol 2019;13:804-811.e2. [PMID: 31383603 DOI: 10.1016/j.jacl.2019.07.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
68 Tatham LM, Liptrott NJ, Rannard SP, Owen A. Long-Acting Injectable Statins-Is It Time for a Paradigm Shift? Molecules 2019;24:E2685. [PMID: 31344834 DOI: 10.3390/molecules24152685] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
69 Thompson W, Jarbøl DE, Haastrup P, Nielsen JB, Pottegård A. Statins in Older Danes: Factors Associated With Discontinuation Over the First 4 Years of Use. J Am Geriatr Soc 2019;67:2050-7. [DOI: 10.1111/jgs.16073] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
70 Eilat-Tsanani S, Mor E, Schonmann Y. Statin Use Over 65 Years of Age and All-Cause Mortality: A 10-Year Follow-Up of 19 518 People. J Am Geriatr Soc 2019;67:2038-44. [PMID: 31287932 DOI: 10.1111/jgs.16060] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
71 Piskovatska V, Strilbytska O, Koliada A, Vaiserman A, Lushchak O. Health Benefits of Anti-aging Drugs. Subcell Biochem 2019;91:339-92. [PMID: 30888659 DOI: 10.1007/978-981-13-3681-2_13] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
72 Kuo HF, Hsieh CC, Wang SC, Chang CY, Hung CH, Kuo PL, Liu YR, Li CY, Liu PL. Simvastatin Attenuates Cardiac Fibrosis via Regulation of Cardiomyocyte-Derived Exosome Secretion. J Clin Med 2019;8:E794. [PMID: 31167519 DOI: 10.3390/jcm8060794] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
73 Yandrapalli S, Gupta S, Andries G, Cooper HA, Aronow WS. Drug Therapy of Dyslipidemia in the Elderly. Drugs Aging 2019;36:321-40. [PMID: 30613912 DOI: 10.1007/s40266-018-00632-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
74 Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-jones D, Lopez-pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC, Sperling L, Virani SS, Yeboah J. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. Journal of the American College of Cardiology 2019;73:e285-350. [DOI: 10.1016/j.jacc.2018.11.003] [Cited by in Crossref: 1009] [Cited by in F6Publishing: 1113] [Article Influence: 252.3] [Reference Citation Analysis]
75 Kim K, Kwak A, Choi CU, Kim JH, Kim MG, Oh JM, Ji E. Differences in preventing new-onset cardiovascular events with statin therapy in seniors aged 75 years and over: A cohort study in the South Korean National Health Insurance Database. Basic Clin Pharmacol Toxicol 2019;125:108-16. [PMID: 30924261 DOI: 10.1111/bcpt.13229] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
76 Ponce OJ, Larrea-mantilla L, Hemmingsen B, Serrano V, Rodriguez-gutierrez R, Spencer-bonilla G, Alvarez-villalobos N, Benkhadra K, Haddad A, Gionfriddo MR, Prokop LJ, Brito JP, Murad MH. Lipid-Lowering Agents in Older Individuals: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. The Journal of Clinical Endocrinology & Metabolism 2019;104:1585-94. [DOI: 10.1210/jc.2019-00195] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
77 Bertolotti M, Lancellotti G, Mussi C. Management of high cholesterol levels in older people. Geriatr Gerontol Int 2019;19:375-83. [PMID: 30900369 DOI: 10.1111/ggi.13647] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
78 Díez-villanueva P, Bonanad Lozano C, García-pardo H, Esteban-fernández A, Carol Ruiz A, Ariza-solé A. Selección de lo mejor del año 2018 en cardiología geriátrica. REC: CardioClinics 2019;54:10-15. [DOI: 10.1016/j.rccl.2019.01.002] [Reference Citation Analysis]
79 Pallazola VA, Sathiyakumar V, Martin SS. Lipid analysis in an aging population. Aging 2019;11:1073-1074. [DOI: 10.18632/aging.101811] [Reference Citation Analysis]
80 Jun JE, Cho IJ, Han K, Jeong IK, Ahn KJ, Chung HY, Hwang YC. Statins for primary prevention in adults aged 75 years and older: A nationwide population-based case-control study. Atherosclerosis 2019;283:28-34. [PMID: 30772771 DOI: 10.1016/j.atherosclerosis.2019.01.030] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
81 Mooradian AD. Evidence-Based Management of Diabetes in Older Adults. Drugs Aging 2018;35:1065-78. [PMID: 30306360 DOI: 10.1007/s40266-018-0598-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
82 Reynolds I, Page RL, Boxer RS. Cardiovascular Health and Healthy Aging. Healthy Aging 2019. [DOI: 10.1007/978-3-030-06200-2_5] [Reference Citation Analysis]
83 Blais JE, Chan EW, Law SW, Mok MT, Huang D, Wong IC, Siu C. Trends in statin prescription prevalence, initiation, and dosing: Hong Kong, 2004–2015. Atherosclerosis 2019;280:174-82. [DOI: 10.1016/j.atherosclerosis.2018.11.015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
84 Trotta F, Caraceni D, Antonicelli R, Cherubini A. Ischemic Heart Disease in Older Adults. Reference Module in Biomedical Sciences 2019. [DOI: 10.1016/b978-0-12-801238-3.11303-0] [Reference Citation Analysis]
85 Mostaza JM, Lahoz C, Salinero-fort MA, Cardenas J. Cardiovascular disease in nonagenarians: Prevalence and utilization of preventive therapies. Eur J Prev Cardiolog 2019;26:356-64. [DOI: 10.1177/2047487318813723] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
86 Piťha J, Topinková E, Blaha V, Jurašková B, Bureš I, Holmerová I, Vrablík M. Statin therapy in elderly patients. Vnitr Lek 2018;64:1021-1027. [DOI: 10.36290/vnl.2018.147] [Reference Citation Analysis]
87 Cowan H. Research Roundup. British Journal of Cardiac Nursing 2018;13:320-321. [DOI: 10.12968/bjca.2018.13.7.320] [Reference Citation Analysis]
88 Spence JD, Hachinski V. B Vitamins for Stroke Prevention. Journal of the American College of Cardiology 2018;71:2147-8. [DOI: 10.1016/j.jacc.2018.03.024] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]